Social networks
2,301 23,701Activities
Technologies
Entity types
Location
101 Cambridgepark Dr, Cambridge, MA 02140, USA
Cambridge
United States of America
Employees
Scale: 201-500
Estimated: 275
Engaged corporates
3Added in Motherbase
1 year, 8 months agoLeading the Microbiome revolution
Seres Therapeutics is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Our lead program, VOWSTTM, obtained U.S. FDA approval in April 2023 as the first orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. We are evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation to reduce incidences of gastrointestinal infections, bloodstream infections, and graft-versus-host disease as well as additional preclinical stage programs targeting Infection Protection in medically compromised patients. We are also conducting research to inform further development of microbiome therapeutics for ulcerative colitis.
For more information, please visit http://www.serestherapeutics.com/ .
Biotechnology, Therapeutics, and Microbiome
Our mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics. Discover our progress.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Prime Time Healthcare Startup accelerator & VC, Publishing, Hospitals and Health Care | Prime Time Healthcare Startup accelerator & VC, Publishing, Hospitals and Health Care | Other 29 Jun 2023 | | |
Seventure Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Seventure Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 27 Apr 2023 | | |
Moderna Pharmaceutical, Biotechnology, Biotechnology Research | Moderna Pharmaceutical, Biotechnology, Biotechnology Research | Other 10 Jan 2022 | |